CTMX · CytomX Therapeutics, Inc. · Debt
$2.44
-0.08 (-2.99%)
At close · Oct 21
Return incl. dividend (before tax)
Market Cap
$546.93M
Shares
217.90M
Volume · Oct 21
1.23M
Avg daily vol (3M)
3.29M
Debt Profile
Completed filing coverage through Nov 6, 2025Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Current operating lease liabilities | 2026-06-30 | USD 1,496,000 | 10-Q filed 2026-08-06 |
| Noncurrent operating lease liabilities | 2026-06-30 | USD 4,208,000 | 10-Q filed 2026-08-06 |
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.
Key facts
CIK
1501989
CUSIP
23284F105
13F (30d)
11 filings
11 filers
Visit website
Investor relations